BRIEF-EU Medicines Agency recommends approval of Novartis' leukaemia drug By: Reuters: Company News July 21, 2017 at 07:37 AM EDT * EU Medicines Agency recommends approval of Pfizer Inc and Merck KGAA Avelumab drug for cell carcinoma Read More >> Related Stocks: Banco Santander ADR Nektar Therapeutics Regeneron Pharmaceuticals Rogers Corp